Stephen Ghiglieri is a veteran corporate officer of life science companies and a newly-appointed Managing Director of the Western Region for Danforth Advisors Big4Bio: As an experienced finance and operations executive, what attracted you to the life sciences? SG: I have spent the majority of my career in life sciences, but it was a departure […]
Spotlight: Explora BioLabs
/ big4bio
Leading the Nation’s Preclinical Vivarium Market Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to biotech clients in development stages from early startup to maturity. With nearly 200,000 square feet of space across 18 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs […]
The Big4Bio Company to Watch Program
September 2021: Molecular Assemblies
September 2021: Molecular Assemblies
/ big4bio
THE COMPANY/THE MISSION Changing the Paradigm for Writing DNA Molecular Assemblies’ leaders detail how the company got started, the company’s technology for synthesizing DNA, and why that technology is better than current methods. THE TECHNOLOGY, PART 1 Moving Synthetic Biology into the 21st Century A deeper look at the company’s enzymatic DNA synthesis […]
The Big4Bio Company to Watch Program
July 2021: Meissa Vaccines
July 2021: Meissa Vaccines
/ big4bio
THE COMPANY/THE MISSION Meissa Vaccines Is Driven to Rid the World of Viral Respiratory Scourges Meissa Vaccines is on a mission to solve a puzzle that has eluded scientists for decades—a pediatric vaccine against respiratory syncytial virus, or RSV. THE PIPELINE Building Single Dose, Intranasal Vaccines to Prevent COVID-19 and RSV Making vaccines […]
The Big4Bio Company to Watch Program
May 2021: Venatorx Pharmaceuticals
May 2021: Venatorx Pharmaceuticals
/ big4bio
THE COMPANY/THE MISSION The Drug Hunter Flying Under the Radar In 2010, Drs. Christopher Burns, Daniel Pevear, and Luigi Xerri set out to build a company focused on anti-infectives; they named it Venatorx, which loosely translated means “Drug Hunter.” THE PIPELINE Addressing the Next Pandemic: Superbugs Venatorx’s lead clinical-stage antibiotics address the growing problem […]
SPOTLIGHT: Big4Bio:SFBay 2020 Year-in-Review
/ big4bio
Welcome to the 2020 Big4Bio Year-in-Review for the San Francisco Bay Area! We hope you enjoy looking back on 2020’s top stories, deals, and M&A that went down in SFBay’s research, pharma, and biotech sectors as we head into 2021. Here’s what you’ll find inside the Year-in-Review 2020 report: Facts about the Bay Area’s life […]
Spotlight Q&A: TFF Pharmaceuticals – Innovative Drug Formulation May Expand Geographic Reach of COVID-19 Vaccines and Treatments
/ big4bio
LaVoieHealthScience Client Spotlight Following is a Q&A with Glenn Mattes, President, CEO and Director of TFF Pharmaceuticals (Nasdaq: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform. Welcome to Big4Bio, Mr. Mattes. Can you share with our readers what is important about […]
Spotlight Q&A: Outlook Therapeutics — Developing First Ophthalmic Formulation of Bevacizumab for FDA Approval
/ big4bio
LaVoieHealthScience Client Spotlight Following is a Q&A with Lawrence Kenyon, President, CEO and CFO of Outlook Therapeutics (NASDAQ: OTLK), a late-stage clinical biotech company focused on developing the first FDA-approved ophthalmic formulation of bevacizumab-vikg to treat wet age-related macular degeneration (wet AMD) and other retinal diseases. By way of background for our readers, age-related macular […]
Big4Bio Q&A: Dror Bashan, CEO of Protalix BioTherapeutics
/ big4bio
LaVoieHealthScience Client Spotlight with Dror Bashan, CEO of Protalix BioTherapeutics Can you provide a brief overview of Protalix BioTherapeutics and its focus? Protalix BioTherapeutics is a unique biopharmaceutical company dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based expression. Protalix was the first company ever to gain FDA approval for […]
Spotlight: Explora BioLabs — Powering Your Science
/ big4bio
Explora BioLabs provides preclinical, AAALAC-accredited vivarium space and related services to clients of all sizes and in all stages of development. With 150,000 square feet of space across 11 locations in biotech-dense communities, the company prides itself on providing clients the ability to initiate preclinical in vivo programs in as little as two weeks, with […]
Big4Bio:SFBay COVID-19 Resource Page
/ big4bio
With more and more communities closing schools and businesses and asking its residents to shelter in place, Big4Bio made a list of online resources where people in our four coverage areas can go to find the latest information about the COVID-19 pandemic and what they should be doing to help stop its spread. (UPDATED WEEKLY) […]
GigaGen Focuses Its Technology to Address COVID-19 Pandemic
/ big4bio
by Marie Daghlian GigaGen announced that it is developing a recombinant polyclonal antibody therapy for the treatment of COVID-19, the pandemic coronavirus that has been sweeping the world and for which humans have no innate immunity. Based in South San Francisco, GigaGen spent the first seven years of its existence developing its single cell technology […]
SPOTLIGHT: Big4Bio:SFBay 2019 Year-in-Review
/ big4bio
Welcome to the first-ever Big4Bio Year-in-Review for the San Francisco Bay Area! We hope you enjoy looking back on 2019’s top stories, deals, and M&A that went down in San Francisco Bay’s research, pharma, and biotech industries as you look ahead to a fruitful 2020. Here’s what you’ll find inside the Year-in-Review 2019 report: Data […]
Big4Bio Interview with Halloran Consulting Group’s Laurie Halloran and Katie McCarthy
/ big4bio
Boston-based Halloran Consulting Group offers senior-level expertise to life science companies as they navigate the regulatory, clinical, and operational challenges at each stage of their development. At the beginning of October, Halloran announced several promotions in its organization, and the expansion of operations in San Diego, setting up a West Coast office there to better […]
Spotlight: Catching Up With CO.DON AG CEO, Ralf Jakobs
/ big4bio
LaVoieHealthScience Client Spotlight: CO.DON CEO, Ralf Jakobs — Advancing Autologous Human Cell Transplants Can you provide a brief overview of CO.DON and its focus? CO.DON is focused on the development, production and marketing of cell-based products for joint-preserving, regenerative treatment of articular cartilage defects. That’s all we do and where we have built our […]